S.C. Ropharma S.A. (BVB:RPH)
0.1530
+0.0010 (0.66%)
At close: May 8, 2025
S.C. Ropharma Income Statement
Financials in millions RON. Fiscal year is January - December.
Millions RON. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 1,191 | 1,006 | 912.74 | 776.69 | 716.27 | Upgrade
|
Other Revenue | 132.11 | 113.83 | 89.23 | 111.47 | 89.58 | Upgrade
|
Revenue | 1,323 | 1,120 | 1,002 | 888.16 | 805.85 | Upgrade
|
Revenue Growth (YoY) | 18.12% | 11.80% | 12.81% | 10.21% | 2.83% | Upgrade
|
Cost of Revenue | 1,030 | 866.05 | 788.1 | 686.93 | 625.55 | Upgrade
|
Gross Profit | 292.79 | 254.14 | 213.88 | 201.23 | 180.31 | Upgrade
|
Selling, General & Admin | 210.7 | 184.61 | 156.95 | 142.62 | 124.74 | Upgrade
|
Other Operating Expenses | 29.03 | 22.86 | 23.88 | 18.34 | 22.32 | Upgrade
|
Operating Expenses | 268.37 | 234.12 | 204.62 | 184.12 | 169.75 | Upgrade
|
Operating Income | 24.42 | 20.02 | 9.26 | 17.11 | 10.55 | Upgrade
|
Interest Expense | -5.86 | -5.56 | -3.44 | -3.21 | -3.26 | Upgrade
|
Interest & Investment Income | 0.08 | 0.08 | 0.03 | 0.24 | 0.03 | Upgrade
|
Currency Exchange Gain (Loss) | -0.33 | -2.08 | -0.25 | -2.43 | -2.35 | Upgrade
|
Other Non Operating Income (Expenses) | 0.43 | 0.46 | 0.75 | 0.27 | -0 | Upgrade
|
EBT Excluding Unusual Items | 18.73 | 12.91 | 6.35 | 11.99 | 4.97 | Upgrade
|
Gain (Loss) on Sale of Assets | 0.93 | 0.18 | 2.81 | 0.95 | 0.03 | Upgrade
|
Asset Writedown | 1.89 | 0.6 | 1.16 | 0.6 | 1.64 | Upgrade
|
Pretax Income | 21.55 | 13.69 | 10.32 | 13.53 | 6.64 | Upgrade
|
Income Tax Expense | 16.17 | 2.01 | 2.82 | 1.96 | 2 | Upgrade
|
Earnings From Continuing Operations | 5.38 | 11.68 | 7.49 | 11.57 | 4.64 | Upgrade
|
Minority Interest in Earnings | -7.1 | -3.96 | 1.72 | -0.84 | 2.12 | Upgrade
|
Net Income | -1.73 | 7.72 | 9.22 | 10.73 | 6.75 | Upgrade
|
Net Income to Common | -1.73 | 7.72 | 9.22 | 10.73 | 6.75 | Upgrade
|
Net Income Growth | - | -16.25% | -14.10% | 58.86% | -10.23% | Upgrade
|
Shares Outstanding (Basic) | 511 | 511 | 511 | 511 | 510 | Upgrade
|
Shares Outstanding (Diluted) | 511 | 511 | 511 | 511 | 510 | Upgrade
|
Shares Change (YoY) | - | - | - | 0.30% | -0.00% | Upgrade
|
EPS (Basic) | -0.00 | 0.02 | 0.02 | 0.02 | 0.01 | Upgrade
|
EPS (Diluted) | -0.00 | 0.02 | 0.02 | 0.02 | 0.01 | Upgrade
|
EPS Growth | - | -16.25% | -14.11% | 58.38% | -10.22% | Upgrade
|
Free Cash Flow | 32.29 | 26.9 | 11.88 | 21.53 | -20.68 | Upgrade
|
Free Cash Flow Per Share | 0.06 | 0.05 | 0.02 | 0.04 | -0.04 | Upgrade
|
Gross Margin | 22.13% | 22.69% | 21.35% | 22.66% | 22.38% | Upgrade
|
Operating Margin | 1.85% | 1.79% | 0.92% | 1.93% | 1.31% | Upgrade
|
Profit Margin | -0.13% | 0.69% | 0.92% | 1.21% | 0.84% | Upgrade
|
Free Cash Flow Margin | 2.44% | 2.40% | 1.19% | 2.42% | -2.57% | Upgrade
|
EBITDA | 41.19 | 36.2 | 24.18 | 31.36 | 25.2 | Upgrade
|
EBITDA Margin | 3.11% | 3.23% | 2.41% | 3.53% | 3.13% | Upgrade
|
D&A For EBITDA | 16.77 | 16.18 | 14.92 | 14.25 | 14.65 | Upgrade
|
EBIT | 24.42 | 20.02 | 9.26 | 17.11 | 10.55 | Upgrade
|
EBIT Margin | 1.85% | 1.79% | 0.92% | 1.93% | 1.31% | Upgrade
|
Effective Tax Rate | 75.04% | 14.69% | 27.38% | 14.48% | 30.15% | Upgrade
|
Revenue as Reported | 1,327 | 1,122 | 1,005 | 890.27 | 810.89 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.